Seaspine Holdings (SPNE) Inventory Turnover Ratio, from third quarter 2022 to third quarter 2021, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Seaspine Holdings Corporation  (NASDAQ: SPNE)
 

Seaspine Holdings Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Seaspine Holdings Corporation inventory turnover ratio, the Seaspine Holdings Corporation's ability to sell and replace its inventory in the third quarter 2022, sequentially increased to 1.15 in the third quarter 2022, yet the ratio remained below the average, as SPNE's market remain challenging.Average inventory processing period, for the Seaspine Holdings in Sep 30 2022 quarter, has decreased to 317 days, compare to 335 days, in the Jun 30 2022 quarter.

Within Healthcare sector 361 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the III Quarter 2022, to 1787, from total ranking in the second quarter 2022 at 1949.

SPNE Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Seaspine Holdings Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SPNE Inventory Turnover Ratio (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter
Y / Y Inventory Growth 18.42 % 31.12 % 31.54 % 33.79 % 37.34 %
Y / Y Cost of Sales Growth 45.64 % 9.41 % 32.6 % 48.75 % 29.95 %
Inventory Turnover Ratio (TTM) 1.15 1.09 1.15 1.15 1.1
SPNE's Total Ranking # 1787 # 1949 # 1778 # 1796 # 1955
Average inventory processing period 317 334 318 317 332
Seq. Inventory Growth -2.23 % 12.25 % 5.86 % 1.93 % 8.27 %
Seq. Cost of Sales Growth 39.26 % -6.13 % -20.8 % 40.67 % 4.62 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 149
Healthcare Sector # 362
Overall Market # 1787

Inventory Turnover Ratio Statistics
High Average Low
1.53 1.23 1.09
(Jun 30 2016)   (Mar 31 2021)



SPNE Company Profile >> Back to SPNE Efficiency Comparisons >> Compare SPNE Inventory Turnover Ratio to its Competitors

Financial Statements
Seaspine Holdings's Inventories $ 84 Millions Visit SPNE's Balance sheet
Seaspine Holdings's Cost of Revenues TTM $ 92 Millions Visit SPNE's Income Statement
What are SPNE's Sales? Visit SPNE's Sales by Segment

Other Inventory Turnover Ratios
Seaspine Holdings's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
SPNE's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for SPNE's Competitors
Inventory Turnover Ratio for SPNE's Suppliers
Inventory Turnover Ratio for SPNE's Customers

You may also want to know
SPNE's Sales Growth Rates SPNE's Pe Price to earnings ratio SPNE's Receivables Turnover Ratio SPNE's Stock Quote
SPNE's Net Income Growth Rates SPNE's Ps Price to Sales ratio SPNE's Sales per Employee SPNE's Asset Turnover Ratio
SPNE's Net Margin SPNE's Pb Price to Book ratio SPNE's Financial Strength Ratios SPNE's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2022, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2022 Inventories at quarter ending Sep 30 2022
Dynatronics Corporation  2.98 $ 33.439  Millions$ 11  Millions
Angiodynamics Inc   2.97 $ 152.887  Millions$ 51  Millions
Sonoma Pharmaceuticals Inc   2.97 $ 8.433  Millions$ 3  Millions
Merck and Co Inc   2.96 $ 16,932.000  Millions$ 5,719  Millions
Neurometrix Inc   2.95 $ 2.466  Millions$ 1  Millions
Celularity Inc   2.92 $ 39.605  Millions$ 14  Millions
Avita Medical Inc   2.92 $ 5.786  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  2.92 $ 55.676  Millions$ 19  Millions
Strata Skin Sciences Inc  2.91 $ 13.696  Millions$ 5  Millions
Dexcom Inc   2.90 $ 978.400  Millions$ 338  Millions
Lannett Company Inc  2.90 $ 282.784  Millions$ 98  Millions
Quidelortho Corp  2.89 $ 1,062.026  Millions$ 367  Millions
American Bio Medica Corporation  2.89 $ 1.186  Millions$ 0  Millions
Vertex Pharmaceuticals Inc  2.89 $ 1,044.387  Millions$ 362  Millions
Inspire Medical Systems inc   2.88 $ 55.119  Millions$ 19  Millions
Enovis Corp  2.88 $ 1,900.501  Millions$ 659  Millions
Biolife Solutions Inc   2.87 $ 90.217  Millions$ 31  Millions
Cytosorbents Corporation  2.87 $ 13.445  Millions$ 5  Millions
Embecta Corp   2.87 $ 354.600  Millions$ 124  Millions
Twist Bioscience Corporation  2.86 $ 119.330  Millions$ 42  Millions
Orthofix Medical Inc   2.84 $ 124.345  Millions$ 44  Millions
Lensar Inc   2.84 $ 17.374  Millions$ 6  Millions
Perrigo Company Plc  2.82 $ 2,964.500  Millions$ 1,052  Millions
Intuitive Surgical Inc   2.82 $ 1,972.000  Millions$ 700  Millions
Johnson and Johnson  2.81 $ 31,279.000  Millions$ 11,122  Millions
Mettler toledo International Inc   2.79 $ 1,239.852  Millions$ 444  Millions
Maravai Lifesciences Holdings Inc   2.77 $ 156.337  Millions$ 56  Millions
Icu Medical Inc  2.74 $ 1,392.202  Millions$ 509  Millions
Heska Corporation  2.72 $ 147.880  Millions$ 54  Millions
Mannkind Corporation  2.71 $ 36.590  Millions$ 14  Millions

Date modified: 2026-08-29T17:30:59+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.